InvestorsHub Logo
Followers 19
Posts 1896
Boards Moderated 0
Alias Born 02/10/2014

Re: lasers post# 10844

Wednesday, 04/09/2014 1:40:56 PM

Wednesday, April 09, 2014 1:40:56 PM

Post# of 48316
Ya. I think that is what ONCS is trying to do. See if they can increase their results with the 21 patient trial. If so and with no safety issues, then I would expect them to use that data to create a phase 2B trial using the increased dosage/frequency data and combining it with an anti-PD-1. Has real potential to bypass phase 3 altogether.